Although LRRC4C itself does not seem to be associated with cancer progression, LRRC4/NGL-2 has been identified as a tumour suppressor gene for glioma and epithelial ovarian cancer 14, 15. This evidence concerns the gene LRRC4 and ovarian carcinoma.